Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease.

PubWeight™: 1.96‹?› | Rank: Top 2%

🔗 View Article (PMID 12454229)

Published in Nephrol Dial Transplant on December 01, 2002

Authors

Adrian Covic1, Mirela Diaconita, Paul Gusbeth-Tatomir, Maria Covic, Adrian Botezan, Gabriel Ungureanu, David J Goldsmith

Author Affiliations

1: C. I. Parhon Hospital, Iasi, Romania, and. Guy's Hospital, London, UK. acovic@xnet.ro

Articles citing this

Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol (2013) 1.62

Autonomic neuropathy and QT interval in hemodialysed patients. Clin Auton Res (2004) 1.48

Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol (2011) 1.17

Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol (2009) 1.06

Myocardial stunning following defibrillation threshold testing. J Interv Card Electrophysiol (2007) 0.88

Changes in QT interval before and after hemodialysis. Caspian J Intern Med (2013) 0.87

Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol (2009) 0.85

Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol (2012) 0.84

Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III. Eur J Epidemiol (2010) 0.83

[Ca²⁺] i-induced augmentation of the inward rectifier potassium current (IK1) in canine and human ventricular myocardium. Pflugers Arch (2013) 0.82

Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients. PLoS One (2015) 0.81

Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol (2015) 0.81

Frailty severity is significantly associated with electrocardiographic QRS duration in chronic dialysis patients. PeerJ (2015) 0.79

Clinical associations between renal dysfunction and vascular events: A literature review. ARYA Atheroscler (2013) 0.79

QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory. Nephron Extra (2011) 0.77

Laboratory markers of ventricular arrhythmia risk in renal failure. Biomed Res Int (2014) 0.77

The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients. Ren Fail (2012) 0.76

Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant (2003) 0.75

The effects of different electrolyte composition in dialysate on QTc interval; a controlled trial. J Renal Inj Prev (2016) 0.75

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients. Clin Pharmacol (2010) 0.75

QT-interval parameters in end-stage renal disease--is cardiovascular autonomic neuropathy unimportant? Clin Auton Res (2004) 0.75

Association of Corrected QT and QT Dispersion with Echocardiographic and Laboratory Findings in Uremic Patients under Chronic Hemodialysis. J Cardiovasc Echogr (2017) 0.75

QT interval in CKD and haemodialysis patients. Clin Kidney J (2013) 0.75

QT intervals and dispersion in patients with acute ischemic stroke. J Natl Med Assoc (2007) 0.75

Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis. J Electrocardiol (2016) 0.75

Articles by these authors

Is it time for spironolactone therapy in dialysis patients? Nephrol Dial Transplant (2006) 1.53

The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function. Perit Dial Int (2004) 1.47

Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5. Nephrol Dial Transplant (2012) 1.45

Have we reached the limits for the treatment of diabetic nephropathy? Expert Opin Investig Drugs (2014) 1.44

Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol Dial Transplant (2007) 1.44

Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transplant (2005) 1.26

A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant (2003) 1.18

Factors affecting the quality of life of haemodialysis patients from Romania: a multicentric study. Nephrol Dial Transplant (2008) 1.11

Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant (2005) 1.08

Arterial stiffness in renal patients: an update. Am J Kidney Dis (2005) 1.05

Vascular calcification in chronic kidney disease. Clin Sci (Lond) (2010) 1.03

Illness representations and quality of life scores in haemodialysis patients. Nephrol Dial Transplant (2004) 1.02

Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised? Nephrol Dial Transplant (2006) 1.00

Synthesis and biological evaluation of aromatic enones related to curcumin. Bioorg Med Chem (2005) 0.97

Tuberculosis complicating tertiary hyperparathyroidism in a patient with end-stage renal disease: a case report. J Nephrol (2008) 0.97

When the kidney catches a cold: an unusual cause of acute renal failure. Nephrol Dial Transplant (2004) 0.95

The challenge of cardiovascular risk factors in end-stage renal disease. J Nephrol (2003) 0.93

Association between the malnutrition-inflammation score and post-transplant anaemia. Nephrol Dial Transplant (2010) 0.93

Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol (2009) 0.92

Cinacalcet for cardiovascular disease in patients undergoing dialysis. N Engl J Med (2013) 0.89

Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin. Bioorg Med Chem Lett (2003) 0.89

Balkan endemic nephropathy: a still unsolved puzzle. J Nephrol (2008) 0.88

The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications. Prog Cardiovasc Dis (2009) 0.88

The success story of peritoneal dialysis in Romania: analysis of differences in mortality by dialysis modality and influence of risk factors in a national cohort. Perit Dial Int (2006) 0.88

Prevalence and management of anaemia in renal transplant recipients: data from ten European centres. Nephron Clin Pract (2010) 0.87

Haemodialysis acutely improves endothelium-independent vasomotor function without significantly influencing the endothelium-mediated abnormal response to a beta 2-agonist. Nephrol Dial Transplant (2004) 0.86

Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up. Int Urol Nephrol (2011) 0.84

Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. J Nephrol (2006) 0.82

Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int (2003) 0.82

Acute liver failure due to leptospirosis successfully treated with MARS (molecular adsorbent recirculating system) dialysis. Int Urol Nephrol (2007) 0.82

A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases. J Indian Med Assoc (2004) 0.81

[Nutritional status evaluation in maintenance hemodialysis patients]. Rev Med Chir Soc Med Nat Iasi (2009) 0.80

Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. J Nephrol (2003) 0.80

Dynamics of the circadian blood pressure profiles after renal transplantation. Transplantation (2005) 0.80

Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session. Hemodial Int (2005) 0.80

Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit. J Nephrol (2006) 0.78

The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study. J Nephrol (2002) 0.77

Once-every-2-weeks and once-weekly epoetin beta regimens: equivalency in hemodialyzed patients. Am J Kidney Dis (2006) 0.77

Trace elements in end-stage renal disease--unfamiliar territory to be revealed. BMC Nephrol (2009) 0.77

Dialysis or not in the very elderly ESRD patient. Int Urol Nephrol (2008) 0.76

Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients. Kidney Int (2005) 0.76

Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome. Int Med Case Rep J (2013) 0.75

FGF23 concentrations measured using "intact" assays similar but not interchangeable. Int Urol Nephrol (2013) 0.75

[Persistent and recurrent skin infection with small-colony variant methicillin-resistant Staphylococcus aureus]. Rev Med Chir Soc Med Nat Iasi (2008) 0.75

[Risk of sudden death in patients with chronic renal failure and hemodialysis]. Rev Med Chir Soc Med Nat Iasi (2005) 0.75

[Epidemiology of biopsy-proven renal disease in Romania: data from a regional registry in north-eastern Romania]. Rev Med Chir Soc Med Nat Iasi (2007) 0.75

[Biological and evolutive spectrum of patients ANCA present]. Rev Med Chir Soc Med Nat Iasi (2005) 0.75

The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic. Int Urol Nephrol (2010) 0.75

[Intravenous iron during predialysis period improves anemia management and cardiovascular parameters in incident hemodialysis patients]. Nephrol Ther (2013) 0.75

[Therapeutic patient education--method of optimizing treatment in chronic diseases]. Rev Med Chir Soc Med Nat Iasi (2007) 0.75

The role of inflammation in acute coronary syndromes: review of the literature. J Med Liban (2005) 0.75

Nephrology and renal replacement therapy in Romania--transition still continues (Cinderella story revisited). Nephrol Dial Transplant (2004) 0.75

Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey. J Hypertens (2017) 0.75

"The Society of Physicians and Naturalists of Iaşi" and the "Medical-Surgical Journal" in Romanian medical life. Rev Med Chir Soc Med Nat Iasi (2014) 0.75

Direct renin inhibitors: ONTARGET for success? Int Urol Nephrol (2009) 0.75

The epidemics of cardiovascular disease in elderly patients with chronic kidney disease--two facets of the same problem. Int Urol Nephrol (2006) 0.75

[Recent advances in molecular pathogenesis and polycystic kidney disease treatment]. Rev Med Chir Soc Med Nat Iasi (2011) 0.75

[Descriptive epidemiologic study of nosocomial infections in "C.I. Parhon" hospital of Iaşi]. Rev Med Chir Soc Med Nat Iasi (2006) 0.75

[Five years of kidney transplantation in Iaşi]. Rev Med Chir Soc Med Nat Iasi (2009) 0.75

Obituary: Professor Valeriu Rusu, MD, Ph.D(1939-2014}. Rev Med Chir Soc Med Nat Iasi (2014) 0.75

[Renal transplantation in the elderly: a survey]. Nephrol Ther (2006) 0.75

Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient. Am J Kidney Dis (2005) 0.75

[Cardiovascular risk after renal transplantation(II): ischemic heart disease, hypercholesterolemia, hyperhomocysteinemia and smoking]. Rev Med Chir Soc Med Nat Iasi (2003) 0.75

[Recent advances in molecular pathogenesis and treatment of polycystic kidney disease]. Rev Med Chir Soc Med Nat Iasi (2008) 0.75

[Retrospective study of 97 ANCA-positive patients: epidemiologic and clinical spectrum]. Rev Med Chir Soc Med Nat Iasi (2005) 0.75

Current dilemmas in inhibiting the renin-angiotensin system: do not forget real life. Int Urol Nephrol (2007) 0.75

Vascular calcification--a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity. Semin Dial (2007) 0.75